WAM
BOLD

Wolverine Asset Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Wolverine Asset Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,800
Closed -$167K – 1859
2019
Q4 		$167K Buy
+2,800
New +$105K ﹤0.01% 1001

Wolverine Asset Management's BOLD Position: Q1 2020 in Review

Wolverine Asset Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 7,091 shares — an estimated $424K sold.

Wolverine Asset Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $424K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Wolverine Asset Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 7,091 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $424K.
  • Wolverine Asset Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Wolverine Asset Management's Audentes Therapeutics, Inc position peaked at $424K in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Wolverine Asset Management's 13F filing for Q1 2020, filed 13 May 2020.